Tag Archive: NIH

Dec
07

Getting to an in vivo active compound

Its been an incredibly fast paced year and hence my posting frequency has suffered. Perhaps its time to get back to writing . Today we had a press release with SRI so that triggered me to fill in the back story. Rewind back to 2014 and the Ebola outbreak was in full flow – see …

Continue reading »

Dec
16

Collaborations Pharmaceuticals, Inc. Announce NIH Award to Develop New Software for Drug Discovery

Today I released the following Collaborations Pharmaceuticals Inc, announcement of our 3rd NIH grant this year. This is an SBIR and will fund software development to provide a tool the company will be able to use in its drug discovery programs but also make commercially available. It will build off our past publications on open …

Continue reading »

Jan
28

Policy: NIH plans to enhance reproducibility

I just read the commentary by Francis Collins and Lawrence Tabak in Nature re: reproducibility.  As we have pointed out before, its possible the NIH should look closer to home for data quality issues. Reproducibility is important, but the databases NIH creates and funds will reach more people and have more impact on science, so …

Continue reading »

Jan
28

Readying for a busy Rare Disease month

February I will be at World Symposium 2014 to represent the various rare disease groups I have been working with, but more generally I will be interested in the progress this community has made since the meeting last year. I will be presenting one poster on the ODDT app and how it has grown to …

Continue reading »